Harmony Biosciences details CEO transition pay in amended 8-K filing

Harmony Biosciences Holdings filed an amendment to its October 13, 2026 Form 8-K on October 30, 2026, to fill in compensation terms for its leadership change that had not been determined at the time of the original filing¹.

Jeffrey M. Dayno is retiring as President and CEO and leaving the board effective December 31, 2026, and will serve as a non-executive advisor to the Company through January 2028¹. Peter Anastasiou, currently Senior Executive Vice President and Chief Operating Officer, has been appointed by the Board to serve as President and Chief Executive Officer of the Company and as a Class I director of the Company's Board, each effective as of January 1, 2027¹.

Under a Separation and Consulting Agreement dated October 29, 2026, Dayno will receive severance under his existing employment and award agreements in exchange for a release of claims and continued compliance with restrictive covenants, and he will continue consulting for the company as an advisor into 2028. During his consultancy, Dr. Dayno will be eligible to receive (x) $500 per hour for any consulting services provided and (y) continued vesting of any Company equity or equity-based awards held by Dr. Dayno as of the Resignation Effective Date based on his continued service with the Company and Harmony Management (or full vesting upon a change in control during the consulting period).¹

Anastasiou's Amended and Restated Executive Employment Agreement, also dated October 29, 2026, sets his annual base salary will be $725,000, effective as of the Appointment Effective Date¹. Commencing with calendar year 2027, Mr. Anastasiou's target annual bonus opportunity will be equal to 75% of his annual base salary under the Company's annual bonus program.¹ Within 30 days of the Appointment Effective Date, he will be eligible for an option award and restricted stock units worth $1,750,000 and $750,000 respectively, vesting 25% on the first anniversary of the appointment and the remainder quarterly through the fourth anniversary, subject to continued service.¹